Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in Testing

Kamboj, Mini; Brite, Jennifer; Aslam, Anoshe; Kennington, Jessica; Babady, N. Esther; Calfee, David; Furuya, Yoko; Chen, Donald; Augenbraun, Michael; Ostrowsky, Belinda; Patel, Gopi; Mircescu, Monica; Kak, Vivek; Tuma, Roman; Karre, Teresa A.; Fry, Deborah A.; Duhaney, Yola P.; Moyer, Amber; Mitchell, Denise; Cantu, Sherry; Hsieh, Candace; Warren, Nancy; Martin, Stacy; Willson, Jill; Dickman, Jeanne; Knight, Julie; Delahanty, Kim; Flood, Annemarie; Harrington, Jennifer; Korenstein, Deborah; Eagan, Janet; Sepkowitz, Kent

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in Testing

Published Date:

Mar 2018

Source:

Emerg Infect Dis. 24(3):584-587.

Language:

English

[PDF-1.06 MB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

Kamboj, Mini ; Brite, Jennifer ; Aslam, Anoshe ; Kennington, Jessica ; Babady, N. Esther ; ... More ▼

Description:

In 2015, Clostridium difficile testing rates among 30 US community, multispecialty, and cancer hospitals were 14.0, 16.3, and 33.9/1,000 patient-days, respectively. Pooled hospital onset rates were 0.56, 0.84, and 1.57/1,000 patient-days, respectively. Higher testing rates may artificially inflate reported rates of C. difficile infection. C. difficile surveillance should consider testing frequency.

Subject:

[+]

Pubmed ID:

29460760

Pubmed Central ID:

PMC5823336

Document Type:

Journal Article

Place as Subject:

United States

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

Supporting Files:

	17-0961-F1.gif	image/gif
	17-0961-F1.jpg	image/jpeg
	17-0961-F2.gif	image/gif
	17-0961-F2.jpg	image/jpeg
	17-0961.nxml	text/xml

No Related Documents.

You May Also Like:

Risk for Clostridiodes difficile Infection among Older Adults with Cancer

Personal Author:

Kamboj, Mini; Gennarelli, Renee L.; Brite, Jennifer; Sepkowitz, Kent; Lipitz-Snyderman, Allison;

Published Date:

Sep 2019

Source:

Emerg Infect Dis. 25(9):1683-1689

Description:

To assess whether risk for Clostridiodes difficile infection (CDI) is higher among older adults with cancer, we conducted a retrospective cohort study with a nested case-control analysis using population-based Surveillance, Epidemiology, and End Resu...

File Type:

[PDF - 821.19 KB]
Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations

Personal Author:

Lessa, Fernanda C.; Mu, Yi; Winston, Lisa G.; Dumyati, Ghinwa K.; Farley, Monica M.; Beldavs, Zintars G.; Kast, Kelly; Holzbauer, Stacy M.; Meek, James I.; Cohen, Jessica; McDonald, L. Clifford; Fridkin, Scott K.;

Published Date:

Jul 28 2014

Source:

Open Forum Infect Dis. 2014; 1(2).

Description:

Background Clostridium difficile infection (CDI) is no longer restricted to hospital settings, and population-based incidence measures are needed. Understanding the determinants of CDI incidence will allow for more meaningful comparisons of rates a...

File Type:

[PDF - 332.64 KB]
National Surveillance for Clostridioides difficile Infection, Sweden, 2009–2016

Personal Author:

Rizzardi, Kristina; Norén, Torbjörn; Aspevall, Olov; Mäkitalo, Barbro; Toepfer, Michael; Johansson, Åsa; Åkerlund, Thomas;

Published Date:

Sep 2018

Source:

Emerg Infect Dis. 24(9):1617-1625.

Description:

We report results from a national surveillance program for Clostridioides difficile infection (CDI) in Sweden, where CDI incidence decreased by 22% and the proportion of multidrug-resistant isolates decreased by 80% during 2012-2016. Variation in inc...

File Type:

[PDF - 2.86 MB]
A Simulation-Based Assessment of Strategies to Control Clostridium Difficile Transmission and Infection

Personal Author:

Rubin, Michael A.; Jones, Makoto; Leecaster, Molly; Khader, Karim; Ray, Willy; Huttner, Angela; Huttner, Benedikt; Toth, Damon; Sablay, Theodore; Borotkanics, Robert J.; Gerding, Dale N.; Samore, Matthew H.;

Published Date:

Nov 21 2013

Source:

PLoS One. 2013; 8(11).

Description:

BackgroundClostridium difficile is one of the most common and important nosocomial pathogens, causing severe gastrointestinal disease in hospitalized patients. Although "bundled" interventions have been proposed and promoted, optimal control strategi...

File Type:

[PDF - 765.01 KB]
Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates

Personal Author:

Guh, Alice Y.; Hatfield, Kelly M.; Winston, Lisa G.; Martin, Brittany; Johnston, Helen; Brousseau, Geoffrey; Farley, Monica M.; Wilson, Lucy; Perlmutter, Rebecca; Phipps, Erin C.; Dumyati, Ghinwa K.; Nelson, Deborah; Hatwar, Trupti; Kainer, Marion A.; Paulick, Ashley L.; Karlsson, Maria; Gerding, Dale N.; McDonald, L. Clifford;

Published Date:

Oct 30 2019

Source:

Clin Infect Dis. 69(10):1667-1674

Description:

BackgroundFew data suggest that Clostridioides difficile infections (CDIs) detected by toxin enzyme immunoassay (EIA) are more severe and have worse outcomes than those detected by nucleic acid amplification tests (NAATs) only. We compared toxin-posi...

Public Access
Available on:

October 30, 2020